We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
35 result(s) found, displaying 31 to 35
-
Prescription medicine decision summaryTGA decision: Ongentys (opicapone) is approved as adjunctive therapy in adult patients with Parkinson's disease.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SEMGLEE insulin glargine (rDNA) 100 IU/mL, 3 mL solution for injection injector pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DICLOFENAC 25 diclofenac potassium 25 mg soft capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DICLOFENAC 12.5 diclofenac potassium 12.5 mg soft capsule blister pack.